Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | GRM5 | P41594 | 2/20 | 0.35 |
| ▸ | PIM1 | P11309 | 1/20 | 0.34 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | DHODH | Q02127 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16357543 | 0.86 | CYP19A1 (0.39) | CYP19A1MAPTPDE10ACYP2C19CYP2C9 | |
| SCHEMBL20426233 | 0.85 | MAPT (0.36) | CYP19A1MAPTALDH1A1G6PD | |
| SCHEMBL20426254 | 0.84 | L3MBTL1 (0.35) | MAPTTP53RAB9ASMN1; SMN2CYP2C19 | |
| SCHEMBL20426224 | 0.82 | MAPT (0.37) | CYP2A6CYP19A1MAPTNPC1RAB9A | |
| SCHEMBL16357501 | 0.82 | CYP19A1 (0.38) | CYP19A1MAPTPDE10ACYP2C19CYP2C9 | |
| SCHEMBL20426249 | 0.82 | CYP3A4 (0.36) | CYP2A6MAPTTSHRNPC1TP53 | |
| SCHEMBL20426141 | 0.81 | CYP19A1 (0.43) | CYP19A1MAPTPDE10ACYP2C19CYP2C9 | |
| SCHEMBL16357470 | 0.81 | MAPT (0.36) | CYP19A1MAPTALDH1A1 | |
| SCHEMBL16357432 | 0.81 | MAPT (0.39) | MAPTTSHRRAB9ASMN1; SMN2CYP2C19 | |
| SCHEMBL20426228 | 0.81 | MAPT (0.39) | MAPTTSHRRAB9ASMN1; SMN2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10038146-B2 | Organic light-emitting compound and organic electroluminescent device using same | DOOSAN CORPORATION (KR) | 2018-07-31 | — | — | US | disclosed |
| US-10038146-B2 | Organic light-emitting compound and organic electroluminescent device using same | DOOSAN CORPORATION (KR) | 2018-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10038146-B2 | Organic light-emitting compound and organic electroluminescent device using same | IDO1, IDO2, KYNU | CYP2A6 2126/4885CYP19A1 870/4885MAPT 459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.